HomeOnkos Surgical

Onkos Surgical

Onkos Surgical® Launches GenVie™

GenVie™ is the first 510(k) cleared magnesium-based bone void filler in the orthopedic marketplace and is available via a private label distribution agreement with Bone Solutions Inc. (OsteoCrete®) announced in late 2019.

Major Milestone Reported: First Patient Entered in the Surgical Oncology Research Team (SORT™) Registry

3/8/18: Onkos Surgical, Inc., a specialty medtech company dedicated to advancing innovation for the surgical oncology market, announced today that Dr. Steven Gitelis and Rush University Medical Center, Chicago, IL, has entered the first patient in the Surgical Oncology Research Team (SORTTM) Registry.